Consortium Spotlight: Advancing Discoveries in Brittle Bone Disorders Dakota Campbell Wed, 11/03/2021 - 11:58
Members of the Brittle Bone Disorders Consortium

The Brittle Bone Disorders Consortium (BBDC) brings together physicians, researchers, and educators to learn more about osteogenesis imperfecta (OI), a genetic disorder that mainly affects the development of the bones. The goal is to develop new and better treatments for patients with OI. Here, principal investigator Brendan Lee, MD, PhD, and Vernon Sutton, MD, share the history of the consortium, current research, and future plans.